INOZYME PHARMA, INC. Patent Applications Pending
26 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-06-02: Application PCTUS2025031978; Invention TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN INFANTS; Applicant INOZYME PHARMA, INC.; Status PCT - International Search Report Mailed to IB.
- 2025-04-18: Application 19183431; Invention NPP1 Fusion Proteins; Applicant Inozyme Pharma, Inc.; Status Docketed New Case - Ready for Examination.
- 2024-11-08: Application 63717958; Invention COMPOSITIONS AND METHODS FOR TREATMENT OF CALCIPHYLAXIS; Applicant Inozyme Pharma, Inc.; Status Provisional Application Expired.
- 2024-10-02: Application 18904807; Invention TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY; Applicant Inozyme Pharma, Inc.; Status Non Final Action Mailed.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2025-06-02 | PCTUS2025031978 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN INFANTS | INOZYME PHARMA, INC. | PCT - International Search Report Mailed to IB | KURT GUNTER YVES SABBAGH | United States United States | KIM, HARRY CHONG HYUN | |
| 2025-04-18 | 19183431 | NPP1 Fusion Proteins | Inozyme Pharma, Inc. | Docketed New Case - Ready for Examination | US20260022356A1 | Anthony Quinn Alex J. Harvey Zhinan Xia | United States United States United States | CENTRAL, DOCKET |
| 2024-11-08 | 63717958 | COMPOSITIONS AND METHODS FOR TREATMENT OF CALCIPHYLAXIS | Inozyme Pharma, Inc. | Provisional Application Expired | Mr. Kurt Gunter | United States | ||
| 2024-10-02 | 18904807 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY | Inozyme Pharma, Inc. | Non Final Action Mailed | US20250170223A1 | Mr. Pedro Huertas Ms. Deborah Wenkert | United States United States | CHOWDHURY, IQBAL HOSSAIN |
| 2024-06-03 | 63655302 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN INFANTS | Inozyme Pharma, Inc. | Provisional Application Expired | Mr. Kurt Gunter Mr. Yves Sabbagh | United States United States | ||
| 2024-03-21 | 18612571 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | Inozyme Pharma, Inc. | Non Final Action Counted, Not Yet Mailed | US20250073319A1 | Mr. Steven Jungles | United States | BOWERS, ERIN M |
| 2023-08-22 | 63578137 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN CHILDREN | Inozyme Pharma, Inc. | Provisional Application Expired | Mr. Kurt Gunter Mr. Yves Sabbagh | United States United States | ||
| 2023-05-18 | 18319821 | Treatment of ENPP1 Deficiency and ABCC6 Deficiency | Inozyme Pharma, Inc. | Notice of Allowance Mailed -- Application Received in Office of Publications | US20240181021A1 | Mr. Pedro Huertas Ms. Deborah Wenkert | United States United States | XIE, XIAOZHEN |
| 2023-04-04 | PCTUS2023065340 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY | INOZYME PHARMA, INC. | PCT - International Search Report Mailed to IB | PEDRO HUERTAS DEBORAH WENKERT | United States United States | THOMAS, SHANE M | |
| 2022-09-23 | PCTUS2022076969 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | INOZYME PHARMA, INC. | PCT - International Search Report Mailed to IB | STEVEN JUNGLES | United States | THOMAS, SHANE M | |
| 2022-04-04 | 63327215 | Treatment of ENPP1 Deficiency and ABCC6 Deficiency | Inozyme Pharma, Inc. | Provisional Application Expired | Pedro Huertas Deborah Wenkert | United States United States | ||
| 2021-11-19 | PCTUS2021060207 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY | INOZYME PHARMA, INC. | PCT - International Search Report Mailed to IB | DEBORAH WENKERT PEDRO HUERTAS | United States United States | KIM, HARRY CHONG HYUN | |
| 2021-09-24 | 63248303 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | Inozyme Pharma, Inc. | Provisional Application Expired | Steven Jungles | United States | ||
| 2021-08-26 | 63237351 | Treatment of ABCC6 Deficiency | Inozyme Pharma, Inc. | Provisional Application Expired | Pedro Huertas Deborah Wenkert | United States United States | ||
| 2021-07-07 | 63219229 | Treatment of ENPP1 Deficiency | Inozyme Pharma, Inc. | Provisional Application Expired | Pedro Huertas | United States | ||
| 2020-11-19 | 63116106 | Treatment of ABCC6 Deficiency | Inozyme Pharma, Inc. | Provisional Application Expired | Pedro Huertas | United States | ||
| 2020-11-19 | 63116093 | Treatment of diseases of pathological calcification | Inozyme Pharma, Inc. | Provisional Application Expired | Pedro Huertas | United States | ||
| 2020-11-19 | 63116086 | Treatment of ENPP1 Deficiency | Inozyme Pharma, Inc. | Provisional Application Expired | Pedro Huertas | United States | ||
| 2020-07-02 | 63047877 | COMPOSITIONS AND METHODS FOR TREATING MOYAMOYA DISEASE AND MOYAMOYA SYNDROME | Inozyme Pharma, Inc. | Provisional Application Expired | Catherine A. Nester Markus Walz Frank Rutsch Yvonne Nitschke | United States United States Germany Germany | ||
| 2020-07-02 | 63047865 | COMPOSITIONS AND METHODS FOR PREVENTING OR INHIBITING INTIMAL PROLIFERATION | Inozyme Pharma, Inc. | Provisional Application Expired | Edward Skolnik Frank Rutsch Yvonne Nitschke | United States Germany Germany | ||
| 2020-07-02 | 63047848 | COMPOSITIONS AND METHODS FOR TREATING ALLOGRAFT VASCULOPATHY | Inozyme Pharma, Inc. | Provisional Application Expired | Damon Banks Markus Walz Frank Rutsch Yvonne Nitschke | United States United States Germany Germany | ||
| 2020-07-02 | 63047793 | COMPOSITIONS AND METHODS FOR TREATING ALLOGRAFT VASCULOPATHY | Inozyme Pharma, Inc. | Provisional Application Expired | Damon Banks Markus Walz Frank Rutsch Yvonne Nitschke | United States United States Germany Germany | ||
| 2019-07-22 | 62877044 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | Inozyme Pharma, Inc. | Provisional Application Expired | Steven Jungles | United States | ||
| 2019-03-21 | 62821692 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | Inozyme Pharma, Inc. | Provisional Application Expired | Steven Jungles | United States | ||
| 2019-01-18 | 62794450 | Treatment Diseases Involving Deficiency of ENPP1 or ENPP3 | Inozyme Pharma, Inc. | Provisional Application Expired | Steven Jungles | United States | ||
| 19512793 | TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY IN CHILDREN | INOZYME PHARMA, INC. | Application Undergoing Preexam Processing | Kurt Gunter Yves Sabbagh | United States United States |